Search results
Innovation, Partnerships & Progress: How Life Sciences Is Booming in Maryland’s Montgomery County
FierceBiotech· 6 hours agoFrom the early wave of fast-breaking COVID-19 vaccines developed by Novavax, to the first-ever...
Novavax, With A 369% Gain, Reverses Bullish Gains After Key FDA Move
Investor's Business Daily· 4 days agoThe vaccine is...But the Novavax Covid vaccine has never been officially approved. Instead, the...
FDA Roundup: June 7, 2024
The Woonsocket Call· 3 days agoToday, the FDA announced that it has advised the manufacturers of the licensed and authorized COVID-19 vaccines that the COVID ...
Novavax's stock surges almost 300% in the past month
Yahoo Finance· 4 days agoUntil now, Novavax's COVID-19 vaccine has only been available through an emergency use authorization (EUA) — a pathway used by the FDA
FDA Roundup: June 7, 2024
Morning Times· 3 days agoToday, the FDA announced that it has advised the manufacturers of the licensed and authorized COVID-19 vaccines that the COVID ...
Why Moderna Stock Is a No-Brainer Buy Right Now | The Motley Fool
The Motley Fool· 8 hours agoIn 2022, the biotech company generated sales of nearly $18.9 billion, but it expects revenue of only...
FDA Green-Lights Moderna Vaccine for Older Adults | Newswise
Newswise· 5 days agoAccording to a company press release, this marks the second approved mRNA product from Moderna and is the only pre-filled syringe available. This approval is also the first ...
Novavax, With A 369% Gain, Tears Ahead Again On A Key FDA Move
Investor's Business Daily· 4 days agoThe news sent Novavax stock more than 2% higher to 21.40 in morning trades. On Wednesday, Novavax...
Should You Pick Moderna Stock At $150 After 25% Gains In A Month?
Forbes· 4 days agoModerna has a couple of factors to back its strong run. Firstly, the U.S. FDA recently approved...
Novavax's stock surges almost 300% in the past month
AOL· 4 days agoNovavax stock (NVAX) is on a tear — soaring nearly 300% in the past month to $19.56 per share — following several pieces of good news. The Food and Drug Administration (FDA